FHA
RVMD icon

First Horizon Advisors’s Revolution Medicines RVMD Stock Holding History

First Horizon Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.27K Buy
89
+31
+53% +$1.19K ﹤0.01% 1929
2025
Q1 		$2.05K Buy
58
+43
+287% +$1.75K ﹤0.01% 1984
2024
Q4 		$656 Hold
15
– – ﹤0.01% 2157
2024
Q3 		$680 Buy
+15
New +$653 ﹤0.01% 2190

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Horizon Advisors's RVMD Position: Q2 2025 in Review

First Horizon Advisors increased its Revolution Medicines (RVMD) stake by 53% in Q2 2025, buying an estimated $1.19K and bringing the position to 89 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

First Horizon Advisors first reported a position in RVMD in Q3 2024 and has held it in 4 quarters since. 308 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

  • First Horizon Advisors held 89 shares of Revolution Medicines worth $3.27K as of Q2 2025.
  • First Horizon Advisors bought 31 Revolution Medicines shares in Q2 2025, an estimated $1.19K.
  • Revolution Medicines made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1929 holding.
  • First Horizon Advisors first reported a position in Revolution Medicines in Q3 2024 and has held it in 4 quarters since.
  • 308 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.